Cresco Labs

As the cannabis industry continues to blossom, it becomes increasingly important to spotlight those at the forefront of the green revolution. In this evolving landscape, visionaries are emerging, shaping the industry, societal perceptions and legal frameworks. Here are the stories and...

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...

The Analyst Columbia Care is being acquired by Cresco Labs (OTC: CRBLF), in a deal set to close by year-end. In a research note published Thursday, Cantor Fitzgerald's Pablo Zuanic kept an overweight rating for (OTC: CCHWF) with a price target of $8.37. “Due to the...

The Analyst: Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC: CRLBF) as Overweight with a price target of $19.00. The Thesis: According to Zuanic, the acquisition of Columbia Care (OTC: CCHWF) fits a logical M&A that is characteristic of the industry's ongoing...

Cresco Labs (OTC: CRLBF) is strengthening its presence in California and other markets through the acquisition of Origin House, which is the trade name for CannaRoyalty Corp (OTC: ORHOF). The value of the all-stock transaction is estimated at C$1.1 billion (about $825 million USD), which makes it...

Chicago-based cannabis cultivator, processor and retailer Cresco Labs (OTC: CRLBF) is launching a subsidiary focused on hemp-derived CBD wellness products that will allow the company to expand across all 50 U.S. states. What Happened The subsidiary, Well Beings, will provide a full line...